These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12899031)

  • 1. [Prohibited marketing and shift in meaning of indications--a case for the IGM].
    Perman E
    Lakartidningen; 2003 Jul; 100(28-29):2378-9. PubMed ID: 12899031
    [No Abstract]   [Full Text] [Related]  

  • 2. [European drug policy: welcomed modernization but shortage of political proposals concerning industry and research].
    Alván G
    Lakartidningen; 2003 Oct; 100(44):3541-2. PubMed ID: 14651017
    [No Abstract]   [Full Text] [Related]  

  • 3. [Public drug marketing scrutinized by IGM and NBL. Conviction in four cases].
    Perman E
    Lakartidningen; 2005 Apr 18-24; 102(16):1262. PubMed ID: 15921101
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward.
    Kravitz RL; Bell RA
    Clin Pharmacol Ther; 2007 Oct; 82(4):360-2. PubMed ID: 17851573
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reporting by the IGM (Information Inspection Team). Marketing of Clarityn disguised as an inquiry].
    Lakartidningen; 1996 Sep; 93(37):3168. PubMed ID: 8847942
    [No Abstract]   [Full Text] [Related]  

  • 6. [Scrutiny of drug marketing by drug industry].
    Perman E
    Lakartidningen; 2003 Apr; 100(16):1444-5. PubMed ID: 12756713
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescribing records and the First Amendment--New Hampshire's data-mining statute.
    Post R
    N Engl J Med; 2009 Feb; 360(8):745-7. PubMed ID: 19228615
    [No Abstract]   [Full Text] [Related]  

  • 8. Data-miners vow to fight bans. Groups claim marketing used to improve quality.
    Blesch G
    Mod Healthc; 2009 Jul; 39(27):15. PubMed ID: 19606667
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug handling is unreasonable in Sweden].
    Fichtelius KE
    Lakartidningen; 1993 Dec; 90(50):4534. PubMed ID: 8264284
    [No Abstract]   [Full Text] [Related]  

  • 10. Off-label or off-limits?
    Ratner M; Gura T
    Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
    [No Abstract]   [Full Text] [Related]  

  • 11. [Who will choose patients' medication in the future? Independent information must be strengthened II].
    Liedholm H; Linné AB; Ekedahl A
    Lakartidningen; 1996 Jun; 93(24):2315-7. PubMed ID: 8684030
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is the drug industry going to pay our professional fight?].
    Hernborg A
    Lakartidningen; 1996 Feb; 93(9):757-8. PubMed ID: 8656876
    [No Abstract]   [Full Text] [Related]  

  • 13. [A serious discussion concerning p-pills is needed].
    Samuelsson E; Hägg S; Håkanson J
    Lakartidningen; 1997 Jul; 94(28-29):2530. PubMed ID: 9254311
    [No Abstract]   [Full Text] [Related]  

  • 14. Organisations question EC changes on drug information for patients.
    Watson R
    BMJ; 2009 Mar; 338():b894. PubMed ID: 19261668
    [No Abstract]   [Full Text] [Related]  

  • 15. [Should we accept defective copies?].
    Ostholm I
    Lakartidningen; 1993 Oct; 90(43):3747-8. PubMed ID: 8231521
    [No Abstract]   [Full Text] [Related]  

  • 16. EC, don't let drug companies give information to the public.
    Currie JA; Preston H; Weerapperuma S
    BMJ; 2009 Jan; 338():b290. PubMed ID: 19174440
    [No Abstract]   [Full Text] [Related]  

  • 17. [Misleading marketing of the use of antibiotics].
    Sörberg M; Forsum U
    Lakartidningen; 1996 Oct; 93(41):3553-4. PubMed ID: 8965508
    [No Abstract]   [Full Text] [Related]  

  • 18. Study affirms PhRMA's influence on physicians.
    Miller JD
    J Natl Cancer Inst; 2007 Aug; 99(15):1148-50. PubMed ID: 17652272
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug companies and the public. EC proposal can be defeated.
    Redding D
    BMJ; 2009 Jan; 338():b291. PubMed ID: 19174441
    [No Abstract]   [Full Text] [Related]  

  • 20. State loses data-mining case. N.H. plans appeal of ruling allowing use of Rx data.
    Conn J
    Mod Healthc; 2007 May; 37(20):32. PubMed ID: 17542311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.